Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
157M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
11.6M
-
Shares change
-
+4.54M
-
Total reported value, excl. options
-
$80.3M
-
Value change
-
+$31.8M
-
Put/Call ratio
-
0.09
-
Number of buys
-
34
-
Number of sells
-
-12
-
Price
-
$6.90
Significant Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q1 2014
58 filings reported holding TGTX - TG THERAPEUTICS, INC. - Common Stock as of Q1 2014.
TG THERAPEUTICS, INC. - Common Stock (TGTX) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.6M shares
of 157M outstanding shares and own 7.4% of the company stock.
Largest 10 shareholders include JPMORGAN CHASE & CO (2.83M shares), BRIDGER MANAGEMENT, LLC (2.55M shares), BAKER BROS. ADVISORS LP (2.16M shares), VANGUARD GROUP INC (733K shares), BlackRock Fund Advisors (459K shares), JENNISON ASSOCIATES LLC (457K shares), COLUMBUS CIRCLE INVESTORS (249K shares), NORTHERN TRUST CORP (218K shares), State Street Corp (209K shares), and SPHERA FUNDS MANAGEMENT LTD. (200K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.